People: Sinopharm Group Co Ltd (SHTDF.PK)

SHTDF.PK on OTC Markets Group

3.19USD
20 Aug 2014
Price Change (% chg)

$0.14 (+4.59%)
Prev Close
$3.05
Open
$3.19
Day's High
$3.19
Day's Low
$3.19
Volume
300
Avg. Vol
2,311
52-wk High
$3.19
52-wk Low
$2.47

Search Stocks

Summary

Name Age Since Current Position

Lulin She

56 2007 Non-Executive Chairman of the Board

Yulin Wei

55 2009 President, General Manager, Executive Director

Xiuchang Jiang

49 2010 Chief Financial Officer

Wanjun Ma

43 2012 Vice President, Joint Company Secretary, Secretary to the Board

Zhongxi Cai

47 2010 Vice President

Guangpu Li

55 2010 Vice President

Zhiming Li

50 2010 Vice President

Yong Liu

44 2009 Vice President

Jun Lu

55 2004 Vice President

Linian Shen

54 2003 Vice President

Jinming Shi

45 2009 Vice President

Shuangjun Xu

43 2011 Vice President

Wanyong Lian

42 2011 Supervisor

Fang Yao

44 Chief Supervisor

Jian Zhang

52 2005 Supervisor

Wei Liu

54 2011 Joint Company Secretary

Qiyu Chen

41 2010 Non-Executive Director

Jindong Deng

48 2007 Non-Executive Director

Banghan Fan

59 2003 Non-Executive Director

Hailiang Liu

63 2003 Non-Executive Director

Qunbin Wang

43 2003 Non-Executive Director

Bin Zhou

46 2011 Non-Executive Director

Ling Li

51 2012 Independent Non-Executive Director

Wuping Tao

57 2003 Independent Non-Executive Director

Fanghua Wang

65 2003 Independent Non-Executive Director

Rong Xie

60 2007 Independent Non-Executive Director

Bajun Zhou

63 2009 Independent Non-Executive Director

Biographies

Name Description

Lulin She

Mr. She Lulin is Non-Executive Chairman of the Board of Sinopharm Group Co., Ltd. He joined the Group as a non-executive Director on 8 January 2003. He was the vice chairman of the Company and has served as the chairman of the Company since 30 August 2007. He has around 29 years of working experience, over 26 years of which is management experience in the pharmaceutical and healthcare products industry. Mr. She obtained a bachelor’s degree in science, majoring in Pharmacy, from Nanjing Pharmaceutical Institution (currently known as China Pharmaceutical University) in July 1982 and a master’s degree in business administration for executives from Tsinghua University in July 2005. Mr. She was previously the deputy head of the general manager’s office, assistant to the general manager, deputy general manager and general manager of China National Pharmaceutical Group Guangzhou Corporation from August 1982 to August 1996. Mr. She was also the vice chairman and general manager of CNPGC from December 1998 to October 2004. Mr. She was a director, general manager and the secretary of Party Committee of CNPGC from October 2004 to October 2009. He was the vice chairman, general manager and deputy secretary of Party Committee of CNPGC since October 2009. Mr. She has been the chairman and legal representative of Sinopharm Industrial Investment Co. Ltd. since July 2008. Mr. She was appointed the chairman of China National Medicines Corporation Ltd. from December 1998 to January 2001.

Yulin Wei

Mr. Wei Yulin is President, General Manager, Executive Director of Sinopharm Group Co., Ltd. He joined the Group on 16 January 2003, and has been an executive Director since 22 December 2008. Mr. Wei was the deputy general manager of the Company from January 2003 to December 2009 and has been the president and the secretary of Party Committee of the Company since December 2009. Mr. Wei has around 35 years of working experience, over 18 years of which is management experience in the pharmaceutical and healthcare products industry. Mr. Wei obtained a master’s degree in business administration for executives from the Cheung Kong Graduate School of Business in January 2007. Mr. Wei is a practicing pharmacist, and was qualified as a senior economist in December 2009. Mr. Wei was also the general manager of Sinopharm Holding Tianjin Co. Ltd. from January 2003 to December 2003 and from October 2004 to April 2006, and its chairman from January 2004 to October 2004. Mr. Wei was also the chairman of each of Sinopharm Holding Shenyang Co. Ltd., Sinopharm Holding Shanxi Co. Ltd., China National Pharmaceutical Group Southwest Medicine Co. Ltd., Sinopharm Holding Hunan Co. Ltd., Sinopharm Holding Zhejiang Co. Ltd., Sinopharm Holding Henan Co. Ltd., Beijing Tianxingpuxin Bio-Medicine, Co. and Yujia Medical Service Co. Ltd., from May 2006 to January 2009, from January 2007 to January 2009, from March 2007 to January 2009, from September 2007 to January 2009, from October 2007 to January 2009, from April 2008 to January 2009, from April 2010 to November 2011 and from September 2010 to November 2011 respectively. In addition, Mr. Wei was a director of China National Pharmaceutical Group Xinjiang Medicines Co. Ltd. from March 2009 to August 2009.

Xiuchang Jiang

Mr. Jiang Xiuchang is Chief Financial Officer of Sinopharm Group Co., Ltd. He joined the Company in May 2010, and has been the chief financial officer of the Company since then. He has 25 years of working experience, 13 years of which is management experience. Mr. Jiang obtained a bachelor’s degree in financial accounting from Zhongnan University of Economics and Law in July 1986 and received his postgraduate education in corporate management from the School of Business of University of International Business and Economics in January 2005. Mr. Jiang joined China Medicines Corporation in July 1986 and was the deputy head of the department of information, reform office, finance department and department of pharmacy from May 1998 to March 2002. He also worked as deputy head, head and chief financial officer of the finance department of China National Medicines Co. Ltd. from March 2002 to May 2010. He is a director of China National Medicines Co. Ltd., China National Accord Medicines Corporation Limited, Sinopharm Lerentang Pharmaceutical Co. Ltd., Sinopharm Holding Hongkong Co. Ltd. and Sinopharm Group Finance Co. Ltd. and the supervisor of Sinopharm Holding Guoda Drug Store Co. Ltd. and Yujia Medical Service Co. Ltd. and Sinopharm Holding Distribution Co. Ltd. and Sinopharm Holding Beijing Co. Ltd.

Wanjun Ma

Mr. Ma Wanjun is Vice President, Joint Company Secretary, Secretary to the Board of Sinopharm Group Co., Ltd. He is also the vice president and board secretary of the Group. Please refer to the section headed “senior management” for Mr. Ma’s biography.

Zhongxi Cai

Mr. Cai Zhongxi is Vice President of Sinopharm Group Co Ltd., since May 2010. He has 22 years of working experience, 20 years of which is management experience. Mr. Cai graduated from the military medical discipline of Second Military Medicine University in July 1989. He obtained a master’s degree in business administration from the School of Management of Maastricht University of the Netherlands in August 2000 and a doctorate degree in business administration from the Southwestern University of the United States in September 2002. Mr. Cai was a doctor of 302 Military Hospital from August 1989 to April 1991. He held various positions in China National Pharmaceutical Group Shanghai Corporation, including deputy manager of specialized medicines department, assistant to general manager, deputy general manager, deputy general manager of general affairs and general manager, from August 1995 to December 2005. He was the chairman of Shanghai Yijia Medical Equipment Co. Ltd from January to July 2006 and was the chairman and general manager of Shanghai Shengtai Medical Technology Co. Ltd. from July 2006 to November 2011. He has also been the chairman of and executive director Shanghai Huyong Medicines Co. Ltd., and a chairman of China National Pharmaceutical Group Shanghai Likang Medicine Co. Ltd. Since October 2010 the chairman of Yujia Medical Service Co. Ltd. and Sinopharm Medicine Holding Beijing HuaHong Co. Ltd. since November 2011.

Guangpu Li

Mr. Li Guangpu is Vice President of Sinopharm Group Co. Ltd., since May 2010. He has 33 years of working experience, 26 years of which is management experience in the pharmaceutical industry. Mr. Li completed his undergraduate education in Chinese medicine at the College of Chinese Traditional Medicine of Guangzhou University of Chinese Medicine in January 1982 and obtained a master’s degree in business administration from Jinan University in Guangzhou in June 2002. He was the general manager of and secretary to the Party Committee of Traditional & Herbal Medicine Company, the vice chairman of China Association of Traditional Chinese Medicine, the pharmaceutical department head and the assistant manager of Guangzhou Medical Station and the general manager of and secretary to the Party Committee of CNPGC from July 2003 to May 2010. He has been the executive director of Sinopharm Logistics Co., Ltd. since October 2010.

Zhiming Li

Mr. Li Zhiming is Vice President of Sinopharm Group Co. Ltd. He joined the Company in May 2010, and has been the vice president since then. He has 31 years of working experience, 21 years of which is management experience. Mr. Li graduated from the economic management discipline of the Urumuqi Branch of Xi’an Military Academy. He was the deputy secretary to the Party Committee, vice chairman and general manager of Xinjiang Pharmaceutical Group Company from October 2003 to January 2008. He was the secretary to the Party Committee, chairman and general manager of Xinjiang Pharmaceutical Group Company from January 2008 to February 2009. He has been the secretary to the Party Committee, chairman and general manager of Xinjiang Company since February 2009. He is the chairman of Sinopharm Holding Tianjin Co. Ltd., Sinopharm Holding Heilongjiang Co. Ltd., Sinopharm Holding Shenyang Co. Ltd., Sinopharm Holding Jilin Co. Ltd., Sinopharm Holding Neimeng Co. Ltd., Sinopharm Holding Ningxia Co. Ltd., Sinopharm Holding Shaanxi Co. Ltd., etc.

Yong Liu

Mr. Liu Yong is Vice President of Sinopharm Group Co., Ltd. Mr. Liu joined the Group on 8 January 2003, and has been a vice president of the Company since 9 January 2009. He has 18 years of working experience, 14 years of which is management experience. Mr. Liu obtained a bachelor’s degree in science, majoring in business administration of pharmaceutical enterprises, from China Pharmaceutical University in July 1992 and a master’s degree in business administration from Fudan University in January 2000. He was previously a deputy general manager of Shanghai Guoda Chain Store from April 2000 to April 2003. Mr. Liu was the general manager of Sinopharm Shenyang from April 2003 to November 2009 and has been the chairman of Sinopharm Shenyang since January 2009. He has been the chairman of Sinopharm Henan since February 2009. He has been the chairman of Sinopharm Anhui and Beijing Kangchen Pharmaceutical Co., Ltd.since May and October 2009, and is currently chairman of Sinopharm Beijing and Sinopharm Jilin and a director of Sinopharm Henan Co. Ltd., Sinopharm Chemical Reagent Ltd., China National Pharmaceutical Group Shanghai Likang Medicine Co. Ltd. and Sinopharm Holding Jilin Co. Ltd. from February 2009 to October 2010, February 2009 to March 2010, February 2009 to October 2010 and May 2010 to November 2011. He is currently the chairman of Sinopharm Holding Anhui Co. Ltd., Sinopharm Holding Beijing Co. Ltd., Beijing Kangchen Pharmaceutical Co. Ltd., China National Medicines Co. Ltd. and Sinopharm Holding Guoda Drug Store Co. Ltd.

Jun Lu

Mr. Lu Jun is a Deputy is Vice President of Sinopharm Group Co., Ltd. Mr. Lu joined the Group on 8 January 2003, and has been a vice president of the Company since 29 June 2004. He served as the assistant to the general manager of the Company, the general manager of medicine retail business department and the head of the investment department of the Company concurrently from April 2003 to June 2004. He has over 33 years of working experience, over 10 years of which is management experience in the pharmaceutical and healthcare products industry. Mr. Lu obtained a master’s degree in business administration (specializing in International Business) from the Maastricht School of Management in August 2001. Mr. Lu was previously the general manager of each of China National Pharmaceutical Group Shanghai Likang Medicine Co., Ltd., Shanghai Guoda Chain Store and Sinopharm Guoda from August 1998 to January 2001, from January 2001 to December 2004 and from June 2004 to June 2008, respectively. Mr. Lu was also a director of Accord Pharma from September 2007 to December 2008 and of Xinjiang Company from March 2009 to August 2009. Mr. Lu has been the chairman of Sinopharm Holding Guoda Drug Store Co. Ltd. and Sinopharm Holding Chongqing Co. Ltd. from July 2008 to November 2011 and from August 2010 to November 2011. He is currently the chairman of Sinopharm Holding Lingyun Co. Ltd., Sinopharm Holding Jiangsu Co. Ltd., Sinopharm Holding Suzhou Co. Ltd., Sinopharm Shandong, Sinopharm Holding Anhui Co. Ltd., Sinopharm Holding Nantong Co. Ltd., Sinopharm Holding Zhejiang Co. Ltd., Sinopharm Holding Wenzhou Co. Ltd.

Linian Shen

Ms. Shen Linian is Vice President of Sinopharm Group Co., Ltd. She joined the Group on 16 January 2003, and has been a vice president of the Company since then. She has 34 years of working experience, 11 years of which is management experience in the pharmaceutical and healthcare products industry. Ms. Shen obtained a master’s degree in business administration (specializing in International Business) from the Maastricht School of Management in August 2001 and completed her graduate education in political economics at Jiangsu Province Administration Institute in July 2006. She was previously an assistant to the general manager and the head of the general manager’s offi ce of China National Pharmaceutical Group Shanghai Corporation from November 1998 to November 1999, and then was their deputy general manager from November 1999 to January 2003. She was the chairman of Sinopharm Holding Shanxi Co. Ltd., Sinopharm Holding Suzhou Co. Ltd. and Sinopharm Holding Gansu Co. Ltd. from May 2010 to November 2011.

Jinming Shi

Mr. Shi Jinming is Vice President of Sinopharm Group Co Ltd. He joined the Group on 8 January 2003, and has been a vice president of the Company since 9 January 2009. He has 21 years of working experience, over 16 years of which is management experience. Mr. Shi obtained a bachelor’s degree in Economics, majoring in trade and economy, from Shanghai University of Finance and Economics in July 1989 and a master’s degree in business administration for executives from Sun Yat-sen University in June 2005. Mr. Shi was previously the general manager of China National Accord Medicines Corporation Ltd. from February 2004 to December 2008, and has been their chairman and director since January 2009. Mr. Shi has been the chairman of each of China National Pharmaceutical Group Southwest Medicine Co. Ltd., Sinopharm Holding Hubei Co. Ltd. and Sinopharm Holding Hunan Co. Ltd. since February 2009, and has been the chairman of each of Sinopharm Holding Yunnan Co. Ltd., Sinopharm Holding Fuzhou Co. Ltd. and Sinopharm Holding Hainan Co. Ltd., Sinopharm Holding Jiangxi Co. Ltd., Sinopharm Holding Guizhou Co. Ltd. and Sinopharm Holding Chongqing Co. Ltd. since November 2009, December 2009 and December 2009, March 2010, March 2010 and November 2011. He is an executive director of Sinopharm Holding Distribution Co. Ltd. and a director of Sinopharm Holding Hongkong Co. Limited.

Shuangjun Xu

Mr. Xu Shuangjun is a Vice President of Sinopharm Group Co. Ltd. He has 27 years of working experience, 18 years of which is management experience in the pharmaceutical industry. He graduated from the School of Pharmacy of the Second Military Medical University in Shanghai and obtained a bachelor’s degree in medicine in 2001. He obtained a master’s degree in business administration from the Macau University of Science and Technology in 2006 and has the qualifi cations of practicing pharmacist and chief pharmacist. He served as a manager of the operating branch of Shijiazhuang City Medicines and Herbs Co., Ltd.from March 1999 to February 2002. He was also the deputy general manager of Shijiazhuang City Medicines and Herbs Co., Ltd. from February 2002 to August 2004. He was the chairman and general manager of Hebei Zhongrui Medicines Co., Ltd. from August 2004 to December 2004. He served as the general manager and secretary to the Party Committee of Shijiazhuang Le Ren Tang Pharmaceutical Co., Ltd. from December 2004 to December 2005. He has been the chairman and general manager of and secretary to the Party Committee of Le Ren Tang Pharmaceutical Group Co., Ltd. since December 2005.

Wanyong Lian

Mr. Lian Wanyong is a Supervisor of Sinopharm Group Co., Ltd. He joined the Company on 22 December 2008 as a non-executive Director and had been a Supervisor since 7 January 2011. He has over 16 years of working experience, all of which is management experience. Mr. Lian obtained a bachelor’s degree in medicine, majoring in clinical medicine, from Hunan University of Medicine (currently known as Central South University Xiangya School of Medicine) in July 1993, a master’s degree in medicine, majoring in pharmacology, from Zhongshan Medicine University (currently known as Zhongshan School of Medicine, Sun Yatsen University) in July 1996 and a master’s degree in business administration from the University of Miami in May 2002. Mr. Lian was previously the manager of the operation and audit department of China National Group Corp. of Traditional & Herbal Medicine and a deputy head of the financial assets management department of CNPGC from January 2004 to June 2005 and from June 2005 to February 2008, respectively. Mr. Lian has been the head of the investment management department of CNPGC since February 2008.

Fang Yao

Mr. Yao Fang is Chief Supervisor of Sinopharm Group Co., Ltd. He has around 21 years of working experience. He obtained a bachelor’s degree in economics from Fudan University in July 1989 and a master of business administration degree from The Chinese University of Hong Kong in December 1993. Mr. Yao served as a Credit Administrator in No.1 Credit Department of Shanghai Branch of Bank of Communications from 1989 to 1991, and worked in Shanghai Wanguo Securities Co. Ltd. (currently known as Shenyin & Wanguo Securities Co. Ltd.) from 1993 to 1996, where his final position was assistant general manager of the International Business Department. Mr. Yao worked in Shanghai Shang Shi Assets Operation and Management Co. Ltd., from June 1996 to December 2002 where his final position was general manager. From January 2003 to October 2005, he served as the general manager of Shang Shi Management (Shanghai) Co. Ltd.. From November 2005 to December 2008, he served as managing director of Shanghai Industrial Pharmaceutical Investment Co. Ltd. (stock code: 600607) listed on Shanghai Stock Exchange. From December 2008 to December 2009, he worked as the chairman of Shanghai Overseas Co. Ltd.. From May 2003 to 31 December 2009, he served as an executive director of Shanghai Industrial Holding Limited(stock code: 0363) listed on Hong Kong Stock Exchange Mr. Yao served as the deputy general manager and the chief financial officer of Shanghai Fosun Pharmaceutical (Group) Co. Ltd. (Stock Code:600196) since April 2010 and became the deputy chairman and president of Shanghai Fosun Pharmaceutical (Group) Co. Ltd. since 9 June 2010. He has served as a non-executive director of Biosion Bio-Technology and Science Incorporation (Stock code: 8247) listed on the Hong Kong Stock Exchange since 24 January 2011. He has been the vice chairman of Shanghai Pharmaceutical Profession Association since June 2010. He has served as the Supervisor of the Company since 7 January 2011.

Jian Zhang

Ms. Zhang Jian is a Supervisor of Sinopharm Group Co., Ltd. She joined the Group on 16 June 2005, and has been a Supervisor since 12 September 2008 and the head of the auditing department of the Company since June 2005. She has around 15 years of working experience. She obtained a bachelor’s degree in economics, majoring in accounting, from Shanghai University of Finance & Economics in July 1997. Ms. Zhang obtained a master degree of EMPACC from Shanghai National Accounting Institute in July 2009. She is a nonpracticing PRC certified public accountant. Ms. Zhang served as an auditor and a project manager of Shanghai Dahua Accounting Firm from July 1997 to November 1999, a project manager of audit department of Delong International Strategic Investment Co., Ltd. from December 1999 to December 2002, and senior manager of audit department of Youlian Strategic Management Research Center from January 2003 to June 2004. Ms. Zhang joined the Group in June 2005 and has also served as the supervisor of Sinopharm Holding Shanxi Co. Ltd., China National Pharmaceutical Group Xinjiang Medicines Co. Ltd., Beijing Tianxingpuxin BioMed Co. Ltd. and Sinopharm Medicine Holding Beijing HuaHong Co. Ltd.

Wei Liu

Dr. Liu Wei is a Joint Company Secretary of Sinopharm Group Co. Ltd., since August 24, 2011. He is the managing partner of China Service and the managing partner of Beijing Office of DLA Piper. Dr. Liu has PRC lawyer qualification and is a solicitor qualified to practice law in Hong Kong and in England. Dr. Liu graduated from the Northwest University of China, the Chinese University of Political Science and Law, the University of Cambridge, with a bachelor in Chinese literature, a master degree in law, a PhD in Law in 1982, 1986 and 1996 respectively. He completed Postgraduate Certificate in Laws (PCLL) with the University of Hong Kong in 2000. Dr. Liu was the first PRC student to obtain a PhD in law from the University of Cambridge after 1949. Dr. Liu worked for several local and state PRC governmental authorities. He is a member of the Shaanxi CPPCC. Dr. Liu is the chairman of DLA Piper’s China Group and the partner in charge of the PRC affairs and practice and he keep a relation with the government of PRC. In 1988, Dr. Liu, as one of the lawyers working in Hong Kong in the early stage, participated in the drafting of the Hong Kong Basic Laws, and then he was retained by the Securities and Futures Commission as a PRC affairs officer responsible for the supervision and policies of red chip shares, H-shares and B-shares, and was responsible for coordination with the China Securities Regulatory Commission, Shenzhen Stock Exchange and Shanghai Stock Exchange.

Qiyu Chen

Mr. Chen Qiyu is a Non-Executive Director of Sinopharm Group Co., Ltd. He joined the Company on 8 January 2003, and had served as the chief Supervisor until 31 May 2010. He has served as a non-executive Director since 31 May 2010. He has around 19 years of working experience. He obtained a bachelor’s degree in genetics from Fudan University in July 1993 and a master’s degree in business administration, majoring in executive business administration, from China Europe International Business School in September 2005. Mr. Chen was previously the deputy general manager, the chief financial officer, the board secretary, general manager, president and vice chairman of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. from July 1998 to May 2010, and has been its director and chairman since May 2005 and June 2010, respectively. He has served as the vice president of Fosun International Limited and Fosun High Technology (Group) Co., Ltd. since August 2010. Mr. Chen has been the chairman of Tianjin Pharmaceuticals Group Co., Ltd. and a supervisor of Shanghai Friendship-Fortune Holding Co. Ltd. and a director of Zhejiang DIAN Diagnostics Co., Ltd. since February 2009, October 2003 and May 2010, respectively. Mr. Chen is also the chairman on duty of China Pharmaceutical industry Research and Development Association, the chairman of Shanghai Biopharmaceutics Industry Association, the vice chairman of China Pharmaceutical Industry Association and the vice-chief commissioner of China Medicinal Biotech Association.

Jindong Deng

Mr. Deng Jindong is Non-Executive Director of Sinopharm Group Co., Ltd. He joined the Group on 30 August 2007, and has been a non-executive Director since then. He has over 25 years of working experience, over 20 years of which is financial management experience. Mr. Deng obtained a bachelor’s degree in economics, majoring in industrial accounting, from Hangzhou Electronics Industry Institution (currently known as Hangzhou Dianzi University) in July 1986 and a master’s degree in economics from Central Institute of Finance and Economics (currently known as Central University of Finance & Economics) in January 1991. He is a non-practicing PRC certified public accountant. Mr. Deng was previously the chief financial officer of Economic Information Network Data Co. Ltd., senior audit manager of Taikang Life Insurance Co. Ltd. and the head of the accounting department of CNPGC from April 2000 to October 2001, from October 2001 to October 2002 and from October 2002 to October 2004, respectively. Mr. Deng has been the chief accountant of CNPGC since October 2004 and a director and the chief financial officer of Sinopharm Industrial Investment Co. Ltd. since July 2008.

Banghan Fan

Mr. Fan Banghan is a Non-Executive Director of Sinopharm Group Co., Ltd. joined the Group on 8 January 2003, and has been a non-executive Director since then. He has around 31 years of working experience, over 28 years of which is management experience in the pharmaceutical and healthcare products industry. Mr. Fan obtained an associate education from Branch Institute of the Shanghai Education Institute, majoring in politics and education, in July 1984. Mr. Fan was a deputy general manager and a director of medicine department of Shanghai Pharmaceutical Co. Ltd. from April 1996 to December 1997. Mr. Fan was a deputy general manager of Shanghai Pharmaceutical Co. Ltd. (a company listed on the Shanghai Stock Exchange) from January 1998 to March 2000 and has been a senior vice president of Shanghai Fosun Pharmaceutical (Group) Co. Ltd. since 2000. Mr. Fan was a supervisor of China National Medicines Corporation Ltd. (a company listed on the Shanghai Stock Exchange) from December 2005 to May 2009. Mr. Fan has been a director of China National Medicines Corporation Ltd. since May 2009. Mr. Fan has been a director and the general manager of Sinopharm Industrial Investment Co. Ltd. since July 2008. Mr. Fan is currently the vice chairman of the Shanghai Pharmaceutical Trade Association.

Hailiang Liu

Mr. Liu Hailiang is Non-Executive Director of Sinopharm Group Co., Ltd. He joined the Group on 8 January 2003, and has been a non-executive Director since then. He has around 43 years of working experience, over 16 years of which is management experience. Mr. Liu obtained an associate education in business administration from Shanghai Construction Institute in September 1986. Mr. Liu was previously the human resources manager of Johnson & Johnson China Ltd. from March 1995 to March 2000. Mr. Liu was an assistant to the general manager and chief human resources supervisor of Shanghai Fosun Pharmaceutical (Group) Co. Ltd. from March 2000 to May 2004, and has been a supervisor and the chief supervisor of Shanghai Fosun Pharmaceutical (Group) Co. Ltd. since May 2004 and May 2008, respectively.

Qunbin Wang

Mr. Wang Qunbin is Non-Executive Director of Sinopharm Group Co., Ltd. joined the Group on 8 January 2003, and has been a non-executive Director since then. He has around 21 years of working experience, over 18 years of which is management experience in biological medicine. Mr. Wang obtained a bachelor’s degree in science, majoring in genetics, from Fudan University in July 1991. Mr. Wang was previously a lecturer at the Genetic Research Institute of Fudan University from September 1991 to September 1993, and then a director and the general manager of Shanghai Fosun Pharmaceutical (Group) Co. Ltd. from 1995 to October 2007 and a director of Tianjin Pharmaceutical Holdings Ltd. from March 2001 to February 2009. Mr. Wang has been the chairman of Shanghai Fosun Pharmaceutical (Group) Co. Ltd. from October 2007 to June 2010, a director and the president of Shanghai Fosun High Technology (Group) Co. Ltd. since November 1994 and January 2009, respectively, as well as a director of Shanghai Friendship-Fortune Holding Co. Ltd. and Sinopharm Industrial Investment Co. Ltd. since September 2000 and July 2008, respectively. Mr. Wang has been a director of Shanghai Friendship Group Incorporated Co. Ltd. (a company listed on the Shanghai Stock Exchange) from September 2000 to 22 June 2010 and Henan Lingrui Pharmaceutical Company Ltd. (a company listed on the Shanghai Stock Exchange) since May 2003, and has also been an executive director and the president of Fosun International Limited (a company listed on the Hong Kong Stock Exchange) since August 2005 and January 2009, respectively. Mr. Wang is currently the chairman of the Huzhou Chamber of Commerce in Shanghai and the vice chairman of China Chamber of International Commerce.

Bin Zhou

Mr. Zhou Bin is Non-Executive Director of Sinopharm Group Co., Ltd. He has served as a non-executive Director since 7 January 2011 and has around 21 years of working experience. He obtained a bachelor’s degree in pharmacology from China Pharmaceutical University in July 1990, a master’s degree in business administration from China Europe International Business School in September 2005 and a doctorate degree in industrial economy from Shanghai Academy of Social Sciences in July 2008. He was a research trainee, a research assistant and an assistant to the director of the department of information of Shanghai Institute of Pharmaceutical Industry from July 1990 to July 1998. He was a deputy director, research assistant and secretary to the branch of the Party at the department of information of Shanghai Institute of Pharmaceutical Industry from July 1998 to December 1999. He was a deputy director, associate researcher and secretary to the branch of the Party at the department of information of Shanghai Institute of Pharmaceutical Industry from December 1999 to May 2002. Mr. Zhou was subsequently a director and a secretary to the branch of the Party at the department of information and the director of the department of market investment of Shanghai Institute of Pharmaceutical Industry from May 2002 to January 2003. He was an assistant dean, the director of the department of market investment and a secretary to the branch of the Party at the department of information of Shanghai Institute of Pharmaceutical Industry and the chairman of Shanghai Institute of Pharmaceutical Industry Pharmaceutical Co. Ltd. from January 2003 to October 2004. He was a vice dean, the director of the department of market investment and the director of the department of information of Shanghai Institute of Pharmaceutical Industry and the chairman of Shanghai Institute of Pharmaceutical Industry Pharmaceutical Co. Ltd. from October 2004 to September 2005.

Ling Li

Ms. Li Ling is a Independent Non-Executive Director of Sinopharm Group Co., Ltd.. She joined the Group on 29 December 2012, and has been an independent not-executive Director since then. Ms. Li has around 30 years of working experience. She obtained a bachelor’s degree in physics in August 1982 and a master’s degree in economics in February 1987 from Wuhan University, and obtained a master’s degree and a doctorate degree in economics from University of Pittsburgh in U.S.A in September 1990 and May 1994, respectively. Ms. Li worked at the Department of Economics of Towson University in Maryland, U.S.A as an associate professor with tenure from August 2000 to August 2003, and also taught at the Department of Economics of University of Pittsburgh in U.S.A and the Department of Management and Marketing of The Hong Kong Polytechnic University. Ms. Li has been a professor and Ph.D. supervisor of economics at China Centre for Economic Research of National School of Development of Peking University since June 2008, and is an expert who enjoys the special allowance of the State Council and is one of the Ten Best Teachers of Peking University. Ms. Li has served as an independent director of PICC Health Insurance Company Limited since 2009. Ms. Li currently also serves as the Deputy Chairman of China Health Economics Association, a member of the State Council Health Reform Advisory Commission, a member of Health Policy and Management Advisory Commission of the Ministry of Health, an evaluation expert in the Pilot Project of Urban Resident Basic Medical Insurance implemented by the State Council, an advisor to the Beijing Municipal Government, an advisor to the pharmaceutical and healthcare reform of Guangdong Province and the Deputy Chairman of Gerontological Society of China.

Wuping Tao

Mr. Tao Wuping is an Independent Non-Executive Director of Sinopharm Group Co., Ltd. He joined the Group on 16 January 2003, and has been an independent non-executive Director since then. Mr. Tao is a lawyer and has over 29 years of working experience as practicing lawyer. Mr. Tao obtained a master’s degree in law, majoring in international economic law, from Fudan University in June 1997. He has been the head of Shen Da Law Firm, a visiting law professor of Shanghai Institute of Foreign Trade, a part-time professor at the Law and Politics College of East China Normal University, and the honorary dean, a part-time professor at the Law and Politics College of Shanghai Normal University and a visiting professor of East China University of Political Science and Law since August 1994, March 2002, June 2003, September 2003 and June 2012, respectively. Mr. Tao was recognized as the “National Outstanding Attorney at Law” by All China Lawyers Association and the first session of “Eastern Attorney at Law” by Shanghai Bar Association.

Fanghua Wang

Mr. Wang Fanghua is Independent Non-Executive Director of Sinopharm Group Co., Ltd. He joined the Group on 16 January 2003, and has been an independent non-executive Director since then. He has 45 years of working experience. He obtained a master’s degree in economics from Fudan University in January 1987 and then worked at Fudan University from July 1994 to April 1998 as assistant to the Dean of the School of Management and the head of the Department of Business Administration of Fudan University. Mr. Wang has been working in the Shanghai Jiaotong University(SJTU) since April 1998. He has served as the vice-dean, general vice-dean and dean of the School of Management, and as the special principal consultant of the university and dean of Institute of Chinese Enterprises Development, SJTU since December 2009. Mr. Wang was an independent director of Shanghai Jinjiang International Hotels Development Co. Ltd. (a company listed on the Shanghai Stock Exchange) from August 2003 to May 2009. Mr. Wang was an independent director of Shanghai Oriental Pearl Co. Ltd. (a company listed on the Shanghai Stock Exchange) from June 2005 to May 2011. Mr. Wang was an independent director of each of Shenzhen Auto Electric Power Plant Co. Ltd. (a company listed on the Shenzhen Stock Exchange),Shanghai New World Co. Ltd. (a company listed on the Shanghai Stock Exchange) and Shanghai Mechanical and Electrical Co. Ltd. (a company listed on the Shanghai Stock Exchange) since March 2007, June 2008 and August 2010 respectively.

Rong Xie

Mr. Xie Rong is an Independent Non-Executive Director of Sinopharm Group Co., Ltd. Mr. Xie joined the Group on 25 April 2005, and has been an independent non-executive Director since 30 August 2007. Before his appointment as an independent non-executive Director was formally approved by the relevant shareholders’ resolution in August 2007, he had already been acting in such capacity since 25 April 2005. He has 43 years of working experience. He obtained a doctorate degree in economics, majoring in accounting from Shanghai University of Finance & Economics, in January 1993. He was previously the deputy head of the Accounting Department of Shanghai University of Finance & Economics and a partner of KPMG China from September 1994 to November 1997 and from December 1997 to October 2002, respectively. Mr. Xie has been a director of SAIC Motor Co., Ltd. (a company listed on the Shanghai Stock Exchange) since April 2003 and was its independent director from April 2003 to June 2008. Mr. Xie was an independent non-executive director of China Shipping Development Company Limited from May 2003 to May 2009. He has been an independent non-executive director of each of China Eastern Airlines Corporation Limited (a company listed on the Hong Kong Stock Exchange and the Shanghai Stock Exchange), China CITIC Bank Corporation Limited (a company listed on the Hong Kong Stock Exchange and the Shanghai Stock Exchange) and Tianjin Capital Environmental Protection Group Company Limited (a company listed on the Hong Kong Stock Exchange and the Shanghai Stock Exchange) since June 2003, February 2007 and April 2008, respectively. Mr. Xie is currently the vice president of the Shanghai National Accounting Institute, a member of the Master of Accounting Professional Education Guidance Committee of the State Department Degree Committee, a standing commissioner of the China Auditing Institute and standing commissioner of the China Accounting Institute.

Bajun Zhou

Mr. Zhou Bajun is Independent Non-Executive Director of Sinopharm Group Co., Ltd. He joined the Group on 19 August 2009, and has been an independent non-executive Director since then. He has over 28 years of working experience, over 12 years of which is in the PRC securities market. Mr. Zhou obtained a doctorate degree in Economics from East China Normal University in October 1988. Mr. Zhou worked as deputy general manager of the China Business Department of Hong Kong Construction (Holdings) Limited (currently known as “Hong Kong Construction (Hong Kong) Limited”) from March 1999 to February 2000. Mr. Zhou has been a senior research fellow of China Everbright Holdings Company Limited since February 2002, and has also been a director and later a responsible officer of China Everbright Research Limited since March 2000 and August 2004, respectively. Mr. Zhou served as a member of the Commission on Strategic Development of the Hong Kong Special Administrative Region from November 2005 to June 2012 and has served as a standing commissioner of the Hong Kong and Macau Research Center of Shanghai Academy of Social Science since March 2007.
Search Stocks